Vjhemonc Video Journal Of Hematology Hemonc

A Phase I/II trial of all-oral DEC-C plus venetoclax in AML ineligible for induction chemotherapy 05:45
A Phase I/II trial of all-oral DEC-C plus venetoclax in AML ineligible for induction chemotherapy VJHemOnc – Video Journal of Hematology & HemOnc 23 7 часов назад
Welcome to the Video Journal of Hematology & Hematological Oncology 🩸 03:08
Welcome to the Video Journal of Hematology & Hematological Oncology 🩸 VJHemOnc – Video Journal of Hematology & HemOnc 1,523 1 год назад
The development of an MVA-based vaccine to prevent complications of infections in patients with CLL 02:41
The development of an MVA-based vaccine to prevent complications of infections in patients with CLL VJHemOnc – Video Journal of Hematology & HemOnc 143 3 дня назад
The current role of CAR T-cell therapy in myeloma and how it is shaping the treatment landscape 03:43
The current role of CAR T-cell therapy in myeloma and how it is shaping the treatment landscape VJHemOnc – Video Journal of Hematology & HemOnc 31 9 часов назад
Ask the Expert: Barbara Eichhorst answers your CLL questions at EHA 2025 09:27
Ask the Expert: Barbara Eichhorst answers your CLL questions at EHA 2025 VJHemOnc – Video Journal of Hematology & HemOnc 172 3 дня назад
Hidden light chain amyloidosis in patients with multiple myeloma 01:45
Hidden light chain amyloidosis in patients with multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 6 8 часов назад
Results of the Phase III AFFIRM-AL trial of birtamimab in AL amyloidosis 01:12
Results of the Phase III AFFIRM-AL trial of birtamimab in AL amyloidosis VJHemOnc – Video Journal of Hematology & HemOnc 56 3 дня назад
An update on immune checkpoint inhibition in MDS & AML: investigating sabatolimab and bexmarilimab 02:40
An update on immune checkpoint inhibition in MDS & AML: investigating sabatolimab and bexmarilimab VJHemOnc – Video Journal of Hematology & HemOnc 137 4 дня назад
Identifying and targeting survival co-dependencies of CLL resistant to venetoclax 01:48
Identifying and targeting survival co-dependencies of CLL resistant to venetoclax VJHemOnc – Video Journal of Hematology & HemOnc 27 1 день назад
Ask the Expert: Rakesh Popat answers your questions on multiple myeloma at EHA 2025 12:18
Ask the Expert: Rakesh Popat answers your questions on multiple myeloma at EHA 2025 VJHemOnc – Video Journal of Hematology & HemOnc 100 4 дня назад
The introduction of non-covalent BTKis to the treatment paradigm for R/R CLL 01:27
The introduction of non-covalent BTKis to the treatment paradigm for R/R CLL VJHemOnc – Video Journal of Hematology & HemOnc 37 3 дня назад
Disparities in mortality trends and age-related outcomes in older adults with DLBCL 00:55
Disparities in mortality trends and age-related outcomes in older adults with DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 18 3 дня назад
The current approach to managing TP53-mutated mantle cell lymphoma 01:28
The current approach to managing TP53-mutated mantle cell lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 68 3 дня назад
Combining ziftomenib with chemotherapy for the treatment of AML: the KOMET trials 02:43
Combining ziftomenib with chemotherapy for the treatment of AML: the KOMET trials VJHemOnc – Video Journal of Hematology & HemOnc 38 3 дня назад
The use of real-world evidence to guide CAR T-cell therapy for patients with LBCL 01:09
The use of real-world evidence to guide CAR T-cell therapy for patients with LBCL VJHemOnc – Video Journal of Hematology & HemOnc 19 3 дня назад
Topline results from the SURPASS-ET trial: ropeginterferon alfa-2b versus anagrelide in ET 01:52
Topline results from the SURPASS-ET trial: ropeginterferon alfa-2b versus anagrelide in ET VJHemOnc – Video Journal of Hematology & HemOnc 59 3 дня назад
The current standard approach to frontline treatment for patients with FLT3-mutated AML 01:40
The current standard approach to frontline treatment for patients with FLT3-mutated AML VJHemOnc – Video Journal of Hematology & HemOnc 36 3 дня назад
The use of golcadomide in combination with R-CHOP for the treatment of aggressive B-cell lymphomas 01:38
The use of golcadomide in combination with R-CHOP for the treatment of aggressive B-cell lymphomas VJHemOnc – Video Journal of Hematology & HemOnc 165 8 месяцев назад
Final results of a pilot study of elotuzumab in patients with myelofibrosis 03:50
Final results of a pilot study of elotuzumab in patients with myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 28 3 дня назад
The Phase III PyramIDH trial: ivosidenib as a treatment for HMA-naive MDS with IDH1 mutation 03:07
The Phase III PyramIDH trial: ivosidenib as a treatment for HMA-naive MDS with IDH1 mutation VJHemOnc – Video Journal of Hematology & HemOnc 19 5 дней назад

Сейчас ищут